Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Feasibility/Phase II Study of hu14.18-IL2 immunocytokine + GM-CSF and Isotretinoin in Patients with Relapsed or Refractory Neuroblastoma: A Groupwide Phase II StudyCIRB: Pediatric CIRBLead Group: COGStatus: CompletedReview Status: Completed
